தொலைபேசி அவிவ் பல்கலைக்கழகம் டாக்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The SARS-CoV-2 virus binds to and enters human cells using its “spike protein”. Vaccines are designed to generate antibodies that bind to the virus’s spike protein and interfere with its ability to infect our cells. Some of the emerging mutations being found in coronavirus variants result in slightly different shaped “spikes”. Previous laboratory studies have found that the antibodies generated either by vaccines or in people who have previously had COVID infections do not bind as tightly to the spikes on some coronavirus variants, and therefore are less effective at neutralizing the variant viruses. Prior to this study, it was not known if this reduction in binding affinity and neutralization would also reduce the effectiveness of vaccines in real-world use.GET THE LATEST BREAKING NEWS HERE SIGN UP FOR GOLOCAL FREE DAILY EBLAST

Rhode islandUnited statesSouth africaSouth africanCovid act nowNick landekicTel aviv university drVirus variant can defeat vaccineHighest infection rateTel aviv universityRhode island newsRhode island sportsRhode island politicsCampaign 2014Digital newsOcean state